Copyright
©The Author(s) 2016.
World J Gastroenterol. May 21, 2016; 22(19): 4638-4650
Published online May 21, 2016. doi: 10.3748/wjg.v22.i19.4638
Published online May 21, 2016. doi: 10.3748/wjg.v22.i19.4638
Figure 2 Janus kinase 2/signal transducer and activator of transcription 3 pathway and inhibitory role of SH2-containing protein tyrosine phosphatase 1.
JAK2: Janus kinase 2; STAT3: Signal transducer and activator of transcription 3; SHP1: SH2-containing protein tyrosine phosphatase 1.
- Citation: Joo MK, Park JJ, Chun HJ. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management. World J Gastroenterol 2016; 22(19): 4638-4650
- URL: https://www.wjgnet.com/1007-9327/full/v22/i19/4638.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i19.4638